Ammar Al-Chalabi, MB, ChB, PhD

Professor of neurology and complex disease genetics, Maurice Wohl Clinical Neuroscience Institute; head, Department of Basic and Clinical Neuroscience; director, Motor Neuron Disease Research Centre, King’s College London


Progress in the Treatment of Amyotrophic Lateral Sclerosis (ALS)

March 17, 2021

Richard S. Bedlack, MD, PhD, MS; Ammar Al-Chalabi, MB, ChB, PhD; Jinsy A. Andrews, MD, MSc; and Jeremy M. Schefner, MD, PhD discuss the current treatment landscape for amyotrophic lateral sclerosis (ALS) and provide insights into ongoing clinical trials and recent results.